AI drug developer Absci partners with Oracle and AMD

Artificial intelligence drug developer Absci announced a partnership with Oracle and AMD to accelerate the process of AI-driven drug discovery. The company's drug discovery platform will utilize Oracle's AI infrastructure and AMD's latest hardware.